 Hematology Clinical research Design of experiments Moroctocog alfa Factor VII Clinical trial Desmopressin Von Willebrand disease Drotrecogin alfa Medicine Haemophilia Health | |  Summary Basis for Regulatory Action Date: [removed]From: Irwin M. Feuerstein, M.D., M.S., M.B.A., Chair of the BLA BLA/STN#: [removed]Applicant Name: Pfizer Incorporated / Wyeth Biopharma Division of Wyeth Pharmaceu
Add to Reading ListSource URL: www.fda.govDownload Document from Source Website File Size: 582,59 KBShare Document on Facebook
|
